Creso Pharma
Melodiol Global Health Limited (formerly Creso Pharma) is an ASX-listed holding company operating a diversified portfolio of plant-based businesses across recreational and medical cannabis, CBD, psychedelics, and natural consumer goods through wholly-owned subsidiaries in Canada, Australia, and Switzerland.
- Company typePublic
- Founded-
- HeadquartersNedlands, Australia
- Headcount1–10
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Creso Pharma does
Melodiol Global Health Limited (formerly Creso Pharma) is an ASX-listed (ASX:ME1) holding company headquartered in Nedlands, Western Australia that operates a diversified portfolio of plant-based businesses across recreational cannabis, medical cannabis, CBD, psychedelics, and natural consumer goods. Its wholly-owned subsidiaries include Mernova (Canadian recreational cannabis produced through a state-of-the-art indoor cultivation facility in Nova Scotia), Health House International (Australian medical cannabis distribution serving patients and healthcare providers), Creso Pharma Switzerland (CBD research, development, and international commercialization), Halucenex Life Sciences (psychedelics applied science), impACTIVE (CBD topical products targeting athletes), and Sierra Sage Herbs (plant-based consumer goods sold through retail and e-commerce).
The company operates a platform-plus-subsidiaries model in which Melodiol acts as the parent brand coordinating complementary operational units across Canada, Australia, and Switzerland. Revenue is generated through five distinct streams — recreational cannabis, medical cannabis distribution, CBD products, psychedelics, and plant-based consumer goods — using a combination of direct cultivation sales, channel/reseller distribution, and e-commerce. Customer segments span recreational cannabis consumers, medical cannabis patients, CBD wellness consumers, psychedelic therapy patients, and health-conscious/athlete consumers. Marketing and investor communication are conducted through ASX announcements, investor presentations, annual and financial reports, and direct email alerts to shareholders.
Creso Pharma firmographics
Firmographics- Name
- Creso Pharma
- Legal name
- Melodiol Global Health Limited
- Website
- https://cresopharma.com
- Company type
- Public
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Melodiol Global Health Limited (formerly Creso Pharma) is an ASX-listed holding company operating a diversified portfolio of plant-based businesses across recreational and medical cannabis, CBD, psychedelics, and natural consumer goods through wholly-owned subsidiaries in Canada, Australia, and Switzerland.
- Ownership category
- akta.pro rank
Creso Pharma industry classification
Industry- Product category
- Cannabis & CBD Products
- NAICS
- Medicinal and Botanical Manufacturing (325411), Pharmaceutical Preparation Manufacturing (325412), Pharmacies and Drug Retailers (45611)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Adult-Use (Recreational) Cannabis Dispensaries (CRANAFAA)
- akta.pro secondary industries
- Medical Cannabis Dispensaries (CRANAFAB), Cannabis Dispensary + Wellness/Apothecary Format (Supplements, Skincare, etc.) (CRANAFAJ)
Keywords
Where Creso Pharma is headquartered
LocationHeadquarters
- HQ city
- Nedlands
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
Creso Pharma business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Others
Revenue model
- Recreational Cannabis: Revenue from recreational cannabis products through Mernova operations in Canada
- Medical Cannabis Distribution: Revenue from medical cannabis distribution through Health House International in Australia
- CBD Products: Revenue from CBD research, development and commercialization through Creso Pharma Switzerland
- Psychedelics: Revenue from psychedelics applied science through Halucenex Life Sciences
- Plant Based Consumer Products: Revenue from plant based consumer goods through Sierra Sage Herbs and impACTIVE product lines
Distribution channels5 records
Marketing channels5 records
Creso Pharma product offering
Product offeringCore offering
Melodiol Global Health Limited (formerly Creso Pharma) curates and delivers a portfolio of plant-based functional products across recreational cannabis, medical cannabis, CBD, psychedelics, and plant-based consumer goods. Operating through wholly-owned subsidiaries (Mernova, Health House International, Creso Pharma Switzerland, Halucenex Life Sciences, impACTIVE, and Sierra Sage Herbs), the company produces, distributes, and commercialises cannabis and CBD products in Canada, Australia, and Switzerland.
Product overview
Melodiol operates as a global platform providing plant-based functional products through a multi-brand portfolio. The core company curates offerings across recreational and medical cannabis, CBD, psychedelics, and plant-based consumer goods. Its portfolio includes Mernova (Canadian recreational cannabis), Health House International (Australian medical cannabis distribution), Creso Pharma Switzerland (CBD R&D and commercialisation), Halucenex Life Sciences (psychedelics applied science), impACTIVE (CBD topical products for athletes), and Sierra Sage Herbs (plant-based consumer products). The architecture functions as a platform-plus-subsidiaries model where Melodiol serves as the parent brand coordinating complementary operational units.
Differentiator
Problem solved
Functional benefit
Products and services
- Mernova Recreational Cannabis
- Health House International Medical Cannabis Distribution
- Creso Pharma Switzerland CBD Products
- Halucenex Life Sciences Psychedelics
- impACTIVE CBD Topical Products
- Sierra Sage Herbs Plant-Based Products
Companies that use Creso Pharma
Customer profileSegments5 records
Ideal customer profiles5 records
Creso Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Creso Pharma partnerships and signals
Strategic signalScale indicators1 record
Recent moves6 records
Expansion highlights5 records
Creso Pharma competitors and assessment
Company assessmentDirect peers
- Compass Pathways: Clinical-stage mental health company developing psilocybin therapy for treatment-resistant depression. Comparable psychedelic applied science and clinical focus to Halucenex.
- Cronos Group: Canadian cannabis producer with international operations and consumer product lines, including CBD wellness. Comparable in the recreational cannabis and CBD verticals.
- Charlotte's Web Holdings: US-based CBD wellness company producing plant-based hemp extract products. Closely comparable to Melodiol's CBD consumer product verticals (Sierra Sage Herbs, impACTIVE).
- Canopy Growth Corporation: Canadian-headquartered cannabis producer with diversified global operations in recreational, medical and CBD. Comparable multi-jurisdictional cannabis platform to Melodiol.
- OrganiGram Holdings: Canadian licensed cannabis producer focused on recreational and medical products. Directly comparable to Mernova's cultivation-driven Canadian business.
- Aurora Cannabis: Canadian licensed cannabis producer with global medical and recreational operations across multiple countries. Directly comparable to Mernova's Canadian cultivation and Melodiol's multi-jurisdiction strategy.
- Mind Medicine (MindMed): Clinical-stage psychedelic medicine company developing psychedelic-assisted therapies. Directly comparable to Melodiol's Halucenex Life Sciences psychedelics subsidiary.
- Tilray Brands: Global cannabis and CPG company with Canadian cultivation, medical distribution and consumer products. Closely comparable across Melodiol's recreational, medical and consumer wellness verticals.
Emerging players
- Zelira Therapeutics: Australia-based clinical-stage cannabinoid and psychedelic medicine company. Closely comparable as a smaller ASX-listed peer operating at the intersection of medical cannabis and psychedelic research.
Broad incumbents
- Curaleaf Holdings: Largest US multi-state cannabis operator with cultivation, processing and retail across recreational and medical. Comparable as a broad incumbent in the cannabis space, though US-focused.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
Creso Pharma social profiles
Digital presenceCreso Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Creso Pharma leadership team
Management profileNumber of profiles
Creso Pharma subsidiaries and ownership
Company hierarchySubsidiaries6 records
Creso Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Creso Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Creso Pharma
What does Creso Pharma do?
Melodiol Global Health Limited (formerly Creso Pharma) curates and delivers a portfolio of plant-based functional products across recreational cannabis, medical cannabis, CBD, psychedelics, and plant-based consumer goods. Operating through wholly-owned subsidiaries (Mernova, Health House International, Creso Pharma Switzerland, Halucenex Life Sciences, impACTIVE, and Sierra Sage Herbs), the company produces, distributes, and commercialises cannabis and CBD products in Canada, Australia, and Switzerland.
Is Creso Pharma a public or private company?
Creso Pharma is a public company. It is classified as public and is currently operating.
When was Creso Pharma founded?
Creso Pharma was founded in -1. It employs 1 to 10 people.
Where is Creso Pharma based?
Creso Pharma is headquartered in Nedlands, Australia, in the Oceania region.
How does Creso Pharma make money?
Five revenue lines are on record. Recreational Cannabis are the primary driver. The others are medical Cannabis Distribution, CBD Products, psychedelics and plant Based Consumer Products.
Who are Creso Pharma's main competitors?
Direct peers on record are Compass Pathways, Cronos Group, Charlotte's Web Holdings, Canopy Growth Corporation, OrganiGram Holdings, Aurora Cannabis, Mind Medicine (MindMed) and Tilray Brands. Zelira Therapeutics is listed as an emerging player. Curaleaf Holdings is listed as a broad incumbent.
Does Creso Pharma have an API?
No public API is recorded for Creso Pharma.
What industry is Creso Pharma in?
Creso Pharma's product category is Cannabis & CBD Products. Its primary akta.pro industry code is CRANAFAA, Adult-Use (Recreational) Cannabis Dispensaries, with a secondary code of CRANAFAB, Medical Cannabis Dispensaries. Its NAICS code is 325411 and its SIC code is 2833.